Literature DB >> 15896181

Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.

David D Martin1, Mark D S Shephard, Hayley Freeman, Max K Bulsara, Timothy W Jones, Elizabeth A Davis, Graeme P Maguire.   

Abstract

OBJECTIVES: To assess the accuracy of point-of-care (POC) measurements of capillary blood glucose and glycosylated haemoglobin (HbA(1c)) levels in a remote Aboriginal community with high diabetes prevalence.
DESIGN: Cross-sectional study comparing POC capillary glucose and HbA(1c) results with those from corresponding venous samples measured in a reference laboratory. PARTICIPANTS AND
SETTING: 152 residents aged 11-76 years (representing 76% of population aged over 11 years) had POC glucose measurement in November 2003; 88 with POC glucose level > or = 5.0 mmol/L, or self-reported diabetes, had POC HbA(1c) and laboratory glucose and HbA(1c) measurements. MAIN OUTCOME MEASURES: POC fasting capillary levels of glucose (HemoCue Glucose 201 analyser, Medipac Scientific, Sydney) and HbA(1c) (DCA 2000+ analyser, Bayer Australia, Melbourne); correlation and mean difference between capillary POC and venous blood laboratory measurements of glucose and HbA(1c).
RESULTS: Mean and median POC capillary glucose levels were 7.99 mmol/L and 6.25 mmol/L, respectively, while mean and median laboratory venous plasma glucose concentrations were 7.63 mmol/L and 5.35 mmol/L. Values for POC capillary HbA(1c) and laboratory HbA(1c) were identical: mean, 7.06%; and median, 6.0%. The correlation coefficient r for POC and laboratory results was 0.98 for glucose and 0.99 for HbA(1c). The mean difference in results was 0.36 mmol/L for glucose (95% CI, 0.13-0.62; limits of agreement [LOA], - 2.07 to 2.79 mmol/L; P = 0.007) and < 0.01% for HbA(1c) (95% CI, - 0.07% to 0.07%; LOA, - 0.66% to 0.66%; P = 0.95), respectively.
CONCLUSIONS: POC capillary HbA(1c) testing, in particular, offers an accurate, practical, community-friendly way of monitoring diabetes in rural and remote clinical settings. POC capillary glucose results should be confirmed by a laboratory test of venous plasma if the results are likely to significantly influence clinical decisions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896181     DOI: 10.5694/j.1326-5377.2005.tb00019.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

Review 1.  Diabetes epidemic in the Asia Pacific region: has hemoglobin A1C finally earned its place as a diagnostic tool?

Authors:  Alexandra Bagley; Usman H Malabu
Journal:  Asian Pac J Trop Biomed       Date:  2014-02

2.  Design and measurement in a study of war exposure, health, and aging: protocol for the Vietnam health and aging study.

Authors:  Kim Korinek; Bussarawan Teerawichitchainan; Zachary Zimmer; Eleanor Brindle; Thi Kim Chuc Nguyen; Huu Minh Nguyen; Khanh Toan Tran
Journal:  BMC Public Health       Date:  2019-10-23       Impact factor: 4.135

3.  Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.

Authors:  Matthew Quigley; Arul Earnest; Naomi Szwarcbard; Natalie Wischer; Sofianos Andrikopoulos; Sally Green; Sophia Zoungas
Journal:  PLoS One       Date:  2022-02-04       Impact factor: 3.240

4.  A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics.

Authors:  Caroline Laurence; Angela Gialamas; Lisa Yelland; Tanya Bubner; Philip Ryan; Kristyn Willson; Briony Glastonbury; Janice Gill; Mark Shephard; Justin Beilby
Journal:  Trials       Date:  2008-08-06       Impact factor: 2.279

5.  Cross-sectional comparison of point-of-care with laboratory HbA₁c in detecting diabetes in real-world remote Aboriginal settings.

Authors:  Julia V Marley; May S Oh; Nyssa Hadgraft; Sally Singleton; Kim Isaacs; David Atkinson
Journal:  BMJ Open       Date:  2015-03-12       Impact factor: 2.692

6.  Pregnancy diabetes: A comparison of diagnostic protocols based on point-of-care, routine and optimized laboratory conditions.

Authors:  Sjoerd A A van den Berg; Monique J M de Groot; Lorenzo P W Salden; Patrick J G J Draad; Ineke M Dijkstra; Simone Lunshof; Sjoerd W van Thiel; Kristel J M Boonen; Marc H M Thelen
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.